Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis
Clinical trial NCT01799538 · RECRUITING
Trial details
- NCT number
- NCT01799538
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-10
- Primary completion
- 2027-11-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.